JP2009517345A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009517345A5 JP2009517345A5 JP2008541550A JP2008541550A JP2009517345A5 JP 2009517345 A5 JP2009517345 A5 JP 2009517345A5 JP 2008541550 A JP2008541550 A JP 2008541550A JP 2008541550 A JP2008541550 A JP 2008541550A JP 2009517345 A5 JP2009517345 A5 JP 2009517345A5
- Authority
- JP
- Japan
- Prior art keywords
- wound
- pharmaceutical composition
- modulating
- ingenol
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010052428 Wound Diseases 0.000 claims 21
- 208000027418 Wounds and injury Diseases 0.000 claims 21
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- VEBVPUXQAPLADL-UHFFFAOYSA-N Ingenol Natural products C1=C(CO)C(O)C2(O)C(O)C(C)=CC32C(C)CC2C(C)(C)C2C1C3=O VEBVPUXQAPLADL-UHFFFAOYSA-N 0.000 claims 13
- -1 ingenol compound Chemical class 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 13
- 238000004519 manufacturing process Methods 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 6
- 108090000695 Cytokines Proteins 0.000 claims 5
- 102000004127 Cytokines Human genes 0.000 claims 5
- 239000002537 cosmetic Substances 0.000 claims 4
- 230000002500 effect on skin Effects 0.000 claims 4
- 210000002950 fibroblast Anatomy 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 4
- 210000002510 keratinocyte Anatomy 0.000 claims 4
- 230000009120 phenotypic response Effects 0.000 claims 4
- 230000029663 wound healing Effects 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 231100000241 scar Toxicity 0.000 claims 3
- VDJHFHXMUKFKET-UHFFFAOYSA-N Ingenol mebutate Natural products CC1CC2C(C)(C)C2C2C=C(CO)C(O)C3(O)C(OC(=O)C(C)=CC)C(C)=CC31C2=O VDJHFHXMUKFKET-UHFFFAOYSA-N 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- VDJHFHXMUKFKET-WDUFCVPESA-N ingenol mebutate Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(CO)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O VDJHFHXMUKFKET-WDUFCVPESA-N 0.000 claims 2
- 229960002993 ingenol mebutate Drugs 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 1
- UQOWJJGOQJONCI-UHFFFAOYSA-N 20-deoxyingenol-3-angelate Natural products CC1CC2C(C)(C)C2C2C=C(C)C(O)C3(O)C(OC(=O)C(C)=CC)C(C)=CC31C2=O UQOWJJGOQJONCI-UHFFFAOYSA-N 0.000 claims 1
- UQOWJJGOQJONCI-MZRDIQIISA-N C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(C)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(C)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O UQOWJJGOQJONCI-MZRDIQIISA-N 0.000 claims 1
- ZYCAGKYWXRKLSN-KLKWOBOISA-N C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(COC(C)=O)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(COC(C)=O)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O ZYCAGKYWXRKLSN-KLKWOBOISA-N 0.000 claims 1
- 206010007710 Cartilage injury Diseases 0.000 claims 1
- 208000028006 Corneal injury Diseases 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 208000034693 Laceration Diseases 0.000 claims 1
- 206010061363 Skeletal injury Diseases 0.000 claims 1
- 206010072170 Skin wound Diseases 0.000 claims 1
- 208000002847 Surgical Wound Diseases 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 238000005299 abrasion Methods 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 230000006835 compression Effects 0.000 claims 1
- 238000007906 compression Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 238000004299 exfoliation Methods 0.000 claims 1
- 125000003147 glycosyl group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- VEBVPUXQAPLADL-POYOOMFHSA-N ingenol Chemical class C1=C(CO)[C@@H](O)[C@]2(O)[C@@H](O)C(C)=C[C@]32[C@H](C)C[C@H]2C(C)(C)[C@H]2[C@H]1C3=O VEBVPUXQAPLADL-POYOOMFHSA-N 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 230000037390 scarring Effects 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 1
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 125000004426 substituted alkynyl group Chemical group 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005906601A AU2005906601A0 (en) | 2005-11-25 | Therapeutic methods and compositions | |
| PCT/AU2006/001781 WO2007059584A1 (en) | 2005-11-25 | 2006-11-24 | Methods for wound healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009517345A JP2009517345A (ja) | 2009-04-30 |
| JP2009517345A5 true JP2009517345A5 (https=) | 2009-12-17 |
Family
ID=38066849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008541550A Pending JP2009517345A (ja) | 2005-11-25 | 2006-11-24 | 創傷治癒の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20090215884A1 (https=) |
| EP (1) | EP1965818A4 (https=) |
| JP (1) | JP2009517345A (https=) |
| KR (1) | KR20080077625A (https=) |
| CN (1) | CN101360506A (https=) |
| BR (1) | BRPI0618926A2 (https=) |
| CA (1) | CA2629899A1 (https=) |
| NZ (1) | NZ568168A (https=) |
| WO (1) | WO2007059584A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ801700A0 (en) | 2000-06-07 | 2000-06-29 | Peplin Research Pty Ltd | Enzyme and viral activation |
| EP1838330A4 (en) | 2004-12-13 | 2010-07-07 | Peplin Research Pty Ltd | TREATMENT OF SOLID TUMORS |
| JP5291369B2 (ja) * | 2008-03-31 | 2013-09-18 | 株式会社ナリス化粧品 | ケラチノサイト増殖促進剤 |
| JP5638008B2 (ja) * | 2009-02-13 | 2014-12-10 | レオ・ラボラトリーズ・リミテッドＬｅｏ Ｌａｂｏｒａｔｏｒｉｅｓ Ｌｉｍｉｔｅｄ | 皮膚治療方法 |
| US8273387B2 (en) | 2009-08-26 | 2012-09-25 | Mary Kay Inc. | Topical skin formulations comprising plant extracts |
| EP2558435B1 (en) | 2010-04-16 | 2017-06-07 | Leo Pharma A/S | Orthorhombic crystalline ingenol mebutate |
| WO2012005876A2 (en) * | 2010-06-30 | 2012-01-12 | Avon Products, Inc. | Compositions and methods for stimulating magp-1 to improve the appearance of skin |
| US9402823B2 (en) | 2010-12-17 | 2016-08-02 | Leo Laboratories Limited | Ingenols for treating seborrheic keratosis |
| JP2014507396A (ja) * | 2010-12-22 | 2014-03-27 | レオ・ラボラトリーズ・リミテッド | イノゲノール−３−アシラートｉ |
| CN103402969A (zh) * | 2010-12-22 | 2013-11-20 | 利奥实验室有限公司 | 3-酰基-巨大戟二萜醇ii |
| RU2572549C2 (ru) * | 2010-12-22 | 2016-01-20 | Лео Лэборетериз Лимитед | Ингенол-3-ацилаты iii и ингенол-3-карбаматы |
| WO2012176015A1 (en) * | 2011-06-24 | 2012-12-27 | Leo Pharma A/S | Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate |
| GB201110777D0 (en) | 2011-06-24 | 2011-08-10 | Aqua Bio Technology Asa | Methods and uses |
| EP2790670A1 (en) * | 2011-12-12 | 2014-10-22 | Leo Laboratories Limited | Gel compositions |
| US20130251782A1 (en) * | 2012-03-22 | 2013-09-26 | Leo Laboratories Limited | Topical application of ingenol mebutate with occlusion |
| CA2875461A1 (en) * | 2012-06-26 | 2014-01-03 | Xifu Liang | 3-o-heteroaryl-ingenol |
| KR20150027831A (ko) * | 2012-07-06 | 2015-03-12 | 레오 파마 에이/에스 | 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물 |
| US9962364B2 (en) | 2012-12-26 | 2018-05-08 | A-Z Ltd. | Wound healing accelerator |
| US20150366789A1 (en) * | 2013-03-13 | 2015-12-24 | Avon Place, Inc. | Glochidium wallichianum extracts and methods of use |
| CN105055448A (zh) * | 2015-05-25 | 2015-11-18 | 中国人民解放军第三军医大学第一附属医院 | 铜离子制剂在制备促进皮肤角质形成细胞增殖药物或敷料中的用途 |
| KR20180118795A (ko) * | 2016-03-18 | 2018-10-31 | 인트렉손 코포레이션 | Vii형 콜라겐 결핍증의 치료를 위한 조성물 및 방법 |
| CN106619600B (zh) * | 2016-03-28 | 2019-10-18 | 中国科学院遗传与发育生物学研究所 | 巨大戟醇及其衍生物在增强溶酶体生成中的应用 |
| CN115677520B (zh) * | 2022-11-18 | 2024-04-02 | 扬州大学 | 一种二萜化合物及其制备方法和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3809749A (en) * | 1971-03-05 | 1974-05-07 | Amazon Natural Drug Co | Topical pharmaceutical composition and method employing sap from the tree croton lechleri |
| DE2902506A1 (de) * | 1979-01-23 | 1980-07-24 | Deutsches Krebsforsch | Verwendung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon als antineoplastische mittel |
| US4418064A (en) * | 1982-09-29 | 1983-11-29 | The United States Of America As Represented By The Secretary Of Agriculture | Chemotherapeutically active maytansinoids: treflorine, trenudine, and N-methyltrenudone |
| US4560774A (en) * | 1982-11-17 | 1985-12-24 | Arizona State University | Macrocyclic lactones |
| US5886017A (en) * | 1986-06-11 | 1999-03-23 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. E. |
| US5145842A (en) * | 1986-06-11 | 1992-09-08 | Alder Research Center Limited Partnership | Protein kinase c. modulators. d. |
| US5886019A (en) * | 1986-06-11 | 1999-03-23 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. F. |
| US5643948A (en) * | 1986-06-11 | 1997-07-01 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. K. |
| US5891906A (en) * | 1986-06-11 | 1999-04-06 | Procyon Pharmaceuticals, Inc. | Polyacetate-derived phorboids having anti-inflammatory and other uses |
| US5891870A (en) * | 1986-06-11 | 1999-04-06 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators Q |
| US5716968A (en) * | 1986-06-11 | 1998-02-10 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. H. |
| US5962498A (en) * | 1986-06-11 | 1999-10-05 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
| US5750568A (en) * | 1986-06-11 | 1998-05-12 | Procyon Pharmaceuticals, Inc. | Protein kinase C Modulators. L. |
| DE4102054A1 (de) * | 1991-01-24 | 1992-07-30 | Geb Szenasi Tamas | Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe |
| US5863938A (en) * | 1991-03-01 | 1999-01-26 | Warner Lambert Company | Antibacterial-wound healing compositions and methods for preparing and using same |
| US5317009A (en) * | 1991-08-26 | 1994-05-31 | New York University | Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| US6593371B1 (en) * | 1993-05-19 | 2003-07-15 | Jeff J. Staggs | Treatment for wart and related disorders |
| US5874464A (en) * | 1995-01-13 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Conformationally constrained diacylglycerol analogues |
| US5932613A (en) * | 1996-07-03 | 1999-08-03 | Millennium Pharmaceuticals, Inc. | Anticancer agents |
| AUPO864097A0 (en) | 1997-08-19 | 1997-09-11 | Peplin Pty Ltd | Anti-cancer compounds |
| DE59901057D1 (de) * | 1999-01-29 | 2002-05-02 | Sid Soc Ind De La Doux S A | Zerkleinerungsvorrichtung mit wenigstens einer drehenden Welle |
| KR20020020808A (ko) * | 1999-08-13 | 2002-03-15 | 스무크 존 | 질병의 광역학적 치료를 위한 국부투여 약물 및 그 방법 |
| JP2001139468A (ja) * | 1999-11-11 | 2001-05-22 | Lead Chemical Co Ltd | 抗ウイルス作用を有するホルボール誘導体 |
| AUPQ801700A0 (en) * | 2000-06-07 | 2000-06-29 | Peplin Research Pty Ltd | Enzyme and viral activation |
| AUPQ923100A0 (en) * | 2000-08-07 | 2000-08-31 | Peplin Research Pty Ltd | Treatment of prostate cancer |
| US6923993B2 (en) * | 2001-12-12 | 2005-08-02 | Nicholas J. Donato | Process of isolating extract from the Euphorbia obesa plant and methods for using the same |
| US7390499B2 (en) * | 2002-04-26 | 2008-06-24 | Lohmann & Rauscher Gmbh | Microbial cellulose wound dressing for treating chronic wounds |
| WO2005043155A1 (en) * | 2003-10-21 | 2005-05-12 | Cedars-Sinai Medical Center | System and method for the treatment of cancer, including cancers of the central nervous system |
| EP1628673B1 (en) * | 2004-01-01 | 2007-03-07 | Panacea Biotec Limited | Pharmaceutical compositions comprising an extract of euphorbia prostrata |
| BRPI0504797B1 (pt) * | 2005-10-27 | 2020-02-04 | Pele Nova Biotecnologia S.A. | formulação tópica, método de tratamento cosmético para rejuvenescimento da pele, método de tratamento cosmético e uso de uma formulação |
-
2006
- 2006-11-24 KR KR1020087014376A patent/KR20080077625A/ko not_active Ceased
- 2006-11-24 EP EP06817537A patent/EP1965818A4/en not_active Withdrawn
- 2006-11-24 WO PCT/AU2006/001781 patent/WO2007059584A1/en not_active Ceased
- 2006-11-24 NZ NZ568168A patent/NZ568168A/en not_active IP Right Cessation
- 2006-11-24 CN CNA2006800516339A patent/CN101360506A/zh active Pending
- 2006-11-24 JP JP2008541550A patent/JP2009517345A/ja active Pending
- 2006-11-24 BR BRPI0618926-1A patent/BRPI0618926A2/pt not_active IP Right Cessation
- 2006-11-24 CA CA002629899A patent/CA2629899A1/en not_active Abandoned
- 2006-11-24 US US12/094,713 patent/US20090215884A1/en not_active Abandoned
-
2016
- 2016-04-18 US US15/131,851 patent/US20160317486A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009517345A5 (https=) | ||
| Knottenbelt | Handbook of Equine Wound Management E-Book: Handbook of Equine Wound Management E-Book | |
| Muangman et al. | A case report: efficiency of microbial cellulose dressing in partial thickness burn wounds | |
| Armstrong | Obesity as an intrinsic factor affecting wound healing | |
| JP2009528406A5 (https=) | ||
| Solanki et al. | A randomised prospective study of split skin graft donor site dressings: AWBAT-D™ vs. Duoderm® | |
| JP5513430B2 (ja) | 炎症を抑制するための薬剤組成物及び方法 | |
| NO20071238L (no) | Fremgangsmater for leging av skader ved human IL-18 administrering | |
| Campiglio et al. | A new protocol for the treatment of hand deformities in recessive dystrophic epidermolysis bullosa (13 cases) | |
| Agale et al. | Marjolin’s Ulcer–a diagnostic dilemma | |
| CA2966724C (en) | Biological film-forming agent for facilitation of wound healing and coating and protection of biological organs | |
| Jordana et al. | The use of vacuum-assisted wound closure to enhance skin graft acceptance in a horse | |
| Yadav et al. | Exploring Commercially Available Formulations For Efficient Wound Healing: A Review | |
| RU2577950C1 (ru) | Способ стимуляции заживления дермальных ожогов | |
| SK9262003A3 (en) | Promoting cell regeneration and/or cell differentiation with non-metabolisable sugar and a polymeric absorbent | |
| RU2780287C1 (ru) | Способ хирургического лечения гипертрофии околоногтевых дистальных и боковых кожных валиков пальцев стоп и кистей | |
| Shankar et al. | A comparative study of collagen granule dressing versus conventional dressing in deep wounds | |
| Çetin et al. | Lyophilised polyurethane membrane dressing for surgically-separated pseudosyndactyly in epidermolysis bullosa | |
| Morioka et al. | Nonsurgical enucleation of plantar epidermal cysts using salicylic acid plaster. | |
| Sobotkaa et al. | Sodium hyaluronate with an iodine complex in the treatment of different wounds | |
| EP2068873B1 (en) | Isoniazid mediated healing of wounds and ulcers | |
| Stone et al. | Anterior Iliac Crest Bone Graft | |
| RU58354U1 (ru) | Иммуномодулирующий бактерицидный перфоративный атравматический лейкопластырь | |
| Munjal et al. | Relaxed skin tension lines and epidermal inclusion cyst: case report | |
| Ridha et al. | The use of Tegaderm™ for finger Buddy-Strapping: a dressing with many advantages |